Genmab — September 2020
-
More ADC reals - SGEN and Merck https://finance.yahoo.com/news/seattle-genetics-merck-announce-two-104500702.html
-
Roche Pharma Day 2020 presentation https://www.roche.com/dam/jcr:c24e5b67-24be-4f06-9380-6c700540e4e9/en/irp20200914.pdf
-
amyloidosis Research Consortium
@Amyloidosis_ARC
· 3 t
Game changer for AL amyloidosis -Janssen Pharmaceutical has filed an application with the US Food and Drug Administration seeking approval for Darzalex Faspro to treat light chain (AL) amyloidosis. http://ow.ly/Di8a50Bq7Hg -
Mosunetuzumab and glofitamab (CD20xCD3)
Potential first in class bispecifics in DLBCL and FL - se side 44 https://www.roche.com/dam/jcr:c24e5b67-24be-4f06-9380-6c700540e4e9/en/irp20200914.pdf -
og igen side 66-68 / Roche har fart på, SC version præsenteres på ASH!
-
God morgen.
-
Genmab
@GenmabJoin us at ESMO20, for an oral presentation on phase 2 innovaTV 204 study evaluating the investigational tisotumab vedotin in patients with recurrent or metastatic #cervicalcancer. Visit our virtual booth to get more info. https://esmo.org/meetings/esmo-virtual-congress-2020
-
Sorry..Link to tweet. https://twitter.com/Genmab/status/1305763362077319169
-
I receive Symphony Health data from pharma- og biotech investors. I dont know anything about af a evnt. split in Dara IV and Dara Faspro.
-
Yes.
-
could use some help on the translation of this chinese article on Amivantamab... https://med.sina.cn/article_detail_103_2_89109.html
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind